Lobbying client

RETROPHIN, INC.

Biopharmaceutical Company

Filings
8
Filed by
1
Reported in-house
—
Reported by firms
$140,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2020

Filings

3 filings for 2020, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2020
COVE STRATEGIES $20,000 reported
2nd Quarter - Report
2nd Quarter 2020
COVE STRATEGIES $20,000 reported
1st Quarter - Report
1st Quarter 2020
COVE STRATEGIES $20,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
COVE STRATEGIES 7 $140,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 8
Health Issues HCR 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 340 116th 6

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.